Concepedia
Statistics
Publications
46
Citations
3K
H-Index
28
Active since
2003
Affiliations
Istituto Oncologico Veneto(Current)
Istituti di Ricovero e Cura a Carattere Scientifico
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
European Institute of Oncology
University of Padua
Jacopo Pigozzo is an author at Istituto Oncologico Veneto specializing in oncology, medicine, and dermatology.
Top concepts
MedicineOncologyDermatologyRadiation OncologyImmunotherapyCancer ResearchPathologyCancer TherapyMolecular OncologyImmunology
Publications per year
2003–2024
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
Pier Francesco Ferrucci, Paolo A. Ascierto, Jacopo Pigozzo et al. · Annals of Oncology · 2016 · 389 citations · Full text
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial
Célèste Lebbé, Nicolás Meyer, Laurent Mortier et al. · Journal of Clinical Oncology · 2019 · 384 citations · Full text
Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
Sara Valpione, Sandro Pasquali, L Campana et al. · Journal of Translational Medicine · 2018 · 193 citations · Full text
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort
Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni et al. · Journal of Translational Medicine · 2014 · 162 citations · Full text
Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma
Michele Del Vecchio, Lorenza Di Guardo, Paolo A. Ascierto et al. · European Journal of Cancer · 2013 · 155 citations · Full text
Ipilimumab 3Mg/kg, Mucosal Melanoma, Medicine +8
1–5 of 46